Fatty acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Holm, Sverre ^a   Ueland, Thor ^a   Dahl, Tuva B ^a   Michelsen, Annika E ^a   Skjelland, Mona ^b   Russell, David ^b,d   Nymo, Ståle H ^a   Krohg Sørensen, Kirsten ^b   Clausen, Ole Petter ^b,d   Atar, Dan ^c,d   Januzzi, James L ^e   Aukrust, Pål ^a,b,d   Jensen, Jesper K ^f   Halvorsen, Bente ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN 4; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; LOW DENSITY LIPOPROTEIN;

ACUTE DISEASE; ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN ISCHEMIA; CAROTID ATHEROSCLEROSIS; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID BINDING PROTEIN 4 GENE; FEMALE; GENE; HEART DEATH; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; AGED; BLOOD; CAROTID ARTERY DISEASE; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; ISCHEMIA; METABOLISM; MIDDLE AGED; MORTALITY; STROKE; THROMBOCYTE; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; ISCHEMIA; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; RNA, MESSENGER; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 83055178179     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028785     Document Type: Article

References (19)

1. Hansson GK, (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695.
2. Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, et al. (2008) Atherosclerotic plaque stability--what determines the fate of a plaque? Prog Cardiovasc Dis 51: 183-194.
3. Makowski L, Hotamisligil GS, (2005) The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Curr Opin Lipidol 16: 543-548.
4. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, et al. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377-1379.
5. Hunt CR, Ro JH, Dobson DE, Min HY, Spiegelman BM, (1986) Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci U S A 83: 3786-3790.
6. Furuhashi M, Hotamisligil GS, (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7: 489-503.
7. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS, (2005) The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem 280: 12888-12895.
8. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7: 699-705.
9. Agardh HE, Folkersen L, Ekstrand J, Marcus D, Swedenborg J, et al. (2011) Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. J Intern Med 269: 200-210.
10. Peeters W, de Kleijn DP, Vink A, van de WS, Schoneveld AH, et al. (2010) Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events. Eur Heart J. In press.
11. Skjelland M, Michelsen AE, Krohg-Sorensen K, Tennoe B, Dahl A, et al. (2007) Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity. Atherosclerosis 195: e142-e146.
12. Jensen JK, Kristensen SR, Bak S, Atar D, Hoilund-Carlsen PF, et al. (2007) Frequency and significance of troponin T elevation in acute ischemic stroke. Am J Cardiol 99: 108-112.
13. Multicenter trial of hemodilution in ischemic stroke--background and study protocol. Scandinavian Stroke Study Group. Stroke 16: 885-890.
14. Otterdal K, Smith C, Oie E, Pedersen TM, Yndestad A, et al. (2006) Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes. Blood 108: 928-935.
15. Dahl TB, Yndestad A, Skjelland M, Oie E, Dahl A, et al. (2007) Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 115: 972-980.
16. Breland UM, Michelsen AE, Skjelland M, Folkersen L, Krohg-Sorensen K, et al. (2010) Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Cardiovasc Res 86: 265-273.
17. Erbay E, Babaev VR, Mayers JR, Makowski L, Charles KN, et al. (2009) Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med 15: 1383-1391.
18. Furuhashi M, Fucho R, Gorgun CZ, Tuncman G, Cao H, et al. (2008) Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 118: 2640-2650.
19. Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, et al. (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447: 959-965.